Schenk, E.L.; Boland, J.M.; Withers, S.G.; Bulur, P.A.; Dietz, A.B.
Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma. Cancers 2022, 14, 4501.
https://doi.org/10.3390/cancers14184501
AMA Style
Schenk EL, Boland JM, Withers SG, Bulur PA, Dietz AB.
Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma. Cancers. 2022; 14(18):4501.
https://doi.org/10.3390/cancers14184501
Chicago/Turabian Style
Schenk, Erin L., Jennifer M. Boland, Sarah G. Withers, Peggy A. Bulur, and Allan B. Dietz.
2022. "Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma" Cancers 14, no. 18: 4501.
https://doi.org/10.3390/cancers14184501
APA Style
Schenk, E. L., Boland, J. M., Withers, S. G., Bulur, P. A., & Dietz, A. B.
(2022). Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma. Cancers, 14(18), 4501.
https://doi.org/10.3390/cancers14184501